{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:31:15Z","timestamp":1772213475888,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejrad.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T11:43:17Z","timestamp":1532086997000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-7047","authenticated-orcid":false,"given":"Davide","family":"Ippolito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-9915","authenticated-orcid":false,"given":"Giulia","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Okolicsanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1728-7653","authenticated-orcid":false,"given":"Cammillo","family":"Talei Franzesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Strazzabosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2018.07.012_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","article-title":"HCC and angiogenesis: possible targets and future directions","volume":"8","author":"Zhu","year":"2011","journal-title":"Nat. Rev. Clin Oncol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0010","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/ijc.25498","article-title":"Vitamin k enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo","volume":"127","author":"Wei","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.suponc.2010.12.007","article-title":"Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse","volume":"9","author":"Manchen","year":"2011","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0030","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1055\/s-0032-1312771","article-title":"Treatment of hepatocellular carcinoma with sorafenib:a focus on special populations and adverse event management","volume":"50","author":"Schott","year":"2012","journal-title":"Z Gastroenterol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0040","doi-asserted-by":"crossref","first-page":"W221","DOI":"10.2214\/AJR.09.3928","article-title":"New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy","volume":"195","author":"Nishino","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0045","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00330-007-0619-9","article-title":"Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions","volume":"17","author":"Rudin","year":"2007","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1148\/radiol.14130091","article-title":"CT perfusion of the liver: principles and applications in oncology","volume":"272","author":"Kim","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/RLI.0b013e3182199bb5","article-title":"Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image bio- markers, CT perfusion, tumor density, and tumor size (RECIST)","volume":"47","author":"Jiang","year":"2012","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0060","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver; European Organization For Research And Treatment Of Cancer","year":"2012","journal-title":"J. Hepatol."},{"issue":"47","key":"10.1016\/j.ejrad.2018.07.012_bib0065","first-page":"5993","article-title":"Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor","volume":"16","author":"Ippolito","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.ejrad.2018.07.012_bib0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.dld.2013.03.004","article-title":"Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study","volume":"45","author":"Sacco","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejrad.2017.02.027","article-title":"Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: a feasibility study","volume":"90","author":"Ippolito","year":"2017","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2018.07.012_bib0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"Ebos","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0090","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1148\/rg.317115108","article-title":"Novel oncologic drugs: what they do and how they affect images","volume":"31","author":"Figueiras","year":"2011","journal-title":"RadioGraphics"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2214\/AJR.09.3964","article-title":"Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization","volume":"195","author":"Monsky","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1148\/radiol.10091870","article-title":"Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification \u2013 preliminary results","volume":"258","author":"Lassau","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2442061189","article-title":"CT perfusion for the monitoring of neo-adjuvant chemoradiation therapy in rectal carcinoma","volume":"244","author":"Bellomi","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0110","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0360-3016(03)00764-8","article-title":"Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head- and-neck cancer after radiotherapy","volume":"57","author":"Hermans","year":"2003","journal-title":"Int. J. Radiat Oncol. Biol. Phys."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0115","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/DCR.0b013e3181afbd79","article-title":"Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer","volume":"52","author":"Hayano","year":"2009","journal-title":"Dis. Colon. Rectum."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00330-008-1128-1","article-title":"Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study","volume":"19","author":"Goh","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1634\/theoncologist.2007-0174","article-title":"Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.26255","article-title":"Comparison of tumor response by response evaluation criteria in solid tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma","volume":"118","author":"Edeline","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0135","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00330-010-1967-4","article-title":"Commercial software upgrades may significantly alter per- fusion CT parameter values in colorectal cancer","volume":"21","author":"Goh","year":"2011","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157340507780619179","article-title":"Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples","volume":"3","author":"Yankeelov","year":"2009","journal-title":"Curr. Med. Imaging Rev."},{"key":"10.1016\/j.ejrad.2018.07.012_bib0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2214\/ajr.185.1.01850225","article-title":"Quantitative assessment of colorectal cancer per- fusion using MDCT: inter- and intraobserver agreement","volume":"185","author":"Goh","year":"2005","journal-title":"AJR"},{"key":"10.1016\/j.ejrad.2018.07.012_bib0150","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1158\/1078-0432.CCR-07-0238","article-title":"Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging","volume":"13","author":"Jackson","year":"2007","journal-title":"Clin. Cancer Res."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18302493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18302493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:02:33Z","timestamp":1535112153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X18302493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"alternative-id":["S0720048X18302493"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.07.012","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}